Loading market dashboard
Fate Therapeutics, Inc.
FATEHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Fate Therapeutics, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $156.38M | $62.32M - $339.95M | -$156.38M | -$0.652 | 3 |
| Dec 2029 | $60.15M | $23.97M - $130.76M | -$60.15M | -$0.91 | 5 |
| Dec 2028 | $5.16M | $2.06M - $11.23M | -$5.16M | -$0.986 | 6 |
| Dec 2027 | $5.27M | $2.10M - $11.46M | -$5.27M | -$0.972 | 7 |
| Dec 2026 | $5.30M | $1.10M - $13.50M | -$5.30M | -$1.084 | 8 |
| Dec 2025 | $6.62M | $6.26M - $7.71M | -$6.62M | -$1.145 | 7 |
| Dec 2024 | $13.30M | $12.38M - $15.78M | -$13.30M | -$1.619 | 9 |
| Dec 2023 | $12.32M | $4.91M - $26.78M | -$12.32M | -$1.691 | 5 |
| Dec 2022 | $69.09M | $63.02M - $77.12M | -$265.67M | -$3.208 | 8 |
| Dec 2021 | $50.85M | $46.38M - $56.76M | -$190.71M | -$2.208 | 7 |
| Dec 2020 | $20.58M | $18.77M - $22.97M | -$126.32M | -$1.832 | 7 |
| Dec 2019 | $9.67M | $8.82M - $10.80M | -$9.67M | -$1.439 | 10 |